Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study

Cardiovascular Diabetology
C R L CardosoG F Salles

Abstract

Long-term visit-to-visit glycemic variability is an additional measure of glycemic control. We aimed to evaluate the prognostic value of several measures of glycemic variability for the occurrence of micro- and macrovascular complications, and all-cause mortality in patients with type 2 diabetes. 654 individuals were followed-up over a median of 9.3 years. Glycemic variability (SDs and coefficients of variation of HbA1c and fasting glycaemia) was measured during the first 12- and 24-months. Multivariate Cox analysis, adjusted for risk factors and mean HbA1c and fasting glycaemia levels, examined the associations between glycemic variability and the occurrence of microvascular (retinopathy, microalbuminuria, renal function deterioration, peripheral neuropathy) and macrovascular complications [total cardiovascular events (CVE), major adverse CVEs (MACE) and cardiovascular mortality], and of all-cause mortality. During follow-up, 128 patients had a CVE (96 MACE), and 158 patients died (67 from cardiovascular diseases); 152 newly-developed or worsened diabetic retinopathy, 183 achieved the renal composite outcome (89 newly developed microalbuminuria and 91 deteriorated renal function), and 96 newly-developed or worsened peripheral ...Continue Reading

References

Mar 5, 2003·Journal of Diabetes and Its Complications·José A Gimeno-OrnaLuis M Lou-Arnal
Apr 13, 2006·JAMA : the Journal of the American Medical Association·Louis MonnierClaude Colette
Apr 13, 2006·JAMA : the Journal of the American Medical Association·Michael Brownlee, Irl B Hirsch
Aug 25, 2006·Nature Clinical Practice. Endocrinology & Metabolism·Per-Henrik GroopMerlin C Thomas
Sep 5, 2006·Diabetes/metabolism Research and Reviews·S Del GuerraP Marchetti
Jun 10, 2008·The New England Journal of Medicine·UNKNOWN Action to Control Cardiovascular Risk in Diabetes Study GroupWilliam T Friedewald
Jun 24, 2008·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·G ZoppiniM Muggeo
Sep 12, 2008·The New England Journal of Medicine·Rury R HolmanH Andrew W Neil
Sep 15, 2009·Diabetes Research and Clinical Practice·Leo NiskanenTero Saukkonen
Jul 9, 2011·Journal of the American Board of Family Medicine : JABFM·Doyle M CummingsDon Holbert
May 26, 2012·Journal of Diabetes and Its Complications·Wen-Ya MaChing-Chieh Su
Aug 24, 2012·Diabetic Medicine : a Journal of the British Diabetic Association·S Rodríguez-SegadeF Camiña
May 4, 2013·Current Diabetes Reports·Samuel T Keating, Assam El-Osta
Sep 3, 2013·The American Journal of Medicine·Cheng-Chieh LinTsai-Chung Li
Mar 14, 2014·The Lancet. Diabetes & Endocrinology·Paul Z ZimmetJonathan E Shaw
Apr 8, 2014·Journal of Diabetes and Its Complications·Toshiko TakaoShoji Kawazu
Sep 23, 2014·The New England Journal of Medicine·Sophia ZoungasUNKNOWN ADVANCE-ON Collaborative Group
Jun 4, 2015·The New England Journal of Medicine·Rodney A HaywardUNKNOWN VADT Investigators
Apr 5, 2016·Journal of Diabetes·Valencia FooCharumathi Sabanayagam
Jun 10, 2016·Diabetic Medicine : a Journal of the British Diabetic Association·J C PrenticeP R Conlin
Aug 10, 2016·Journal of Diabetes and Its Complications·Neda LaiteerapongElbert S Huang
Dec 17, 2016·Diabetes Care·UNKNOWN American Diabetes Association

❮ Previous
Next ❯

Citations

Aug 1, 2019·Diabetes, Obesity & Metabolism·Emma G WilmotMike Baxter
Jun 23, 2020·The Journal of International Medical Research·Maria Isabel Del Olmo-GarcíaJuan Francisco Merino-Torres
Aug 9, 2020·The Journal of Clinical Endocrinology and Metabolism·Emma S ScottAlicia J Jenkins
Jul 13, 2018·International Journal of Endocrinology·I MigdalisP Valensi
Sep 15, 2018·Diabetology & Metabolic Syndrome·Miho AkazaTakanori Yokota
Dec 14, 2019·Cardiovascular Diabetology·Roderick C SliekerJoline W J Beulens
Apr 19, 2020·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Boris KovatchevMarc D Breton
Jul 6, 2020·Cardiovascular Diabetology·Zheng ZhouMeng Bian
Feb 2, 2019·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Penelope J TaylorGrant D Brinkworth
Feb 26, 2019·International Heart Journal·Masaya SakamotoYosuke Kayama
Sep 29, 2020·Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy·Luciana Neves Cosenso-MartinJose Fernando Vilela-Martin
Nov 27, 2019·European Journal of Preventive Cardiology·Paul ValensiAntonio Ceriello
Oct 20, 2020·Frontiers in Endocrinology·Marie Mathilde Bjerg ChristensenChristian Stevns Hansen
Nov 13, 2020·Diabetic Medicine : a Journal of the British Diabetic Association·Viktor Rotbain CurovicPeter Rossing
Dec 18, 2020·Expert Opinion on Investigational Drugs·Ernest A AdeghateKornelia Tekes
Dec 29, 2020·The Journal of Clinical Endocrinology and Metabolism·Jin J ZhouPeter Reaven
Jul 10, 2019·Journal of Diabetes Science and Technology·Channabasappa ShivaprasadPremchander Aarudhra

❮ Previous
Next ❯

Methods Mentioned

BETA
urine collections
amputation

Software Mentioned

Graph
Mobil
SPSS

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.